These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20010137)

  • 1. Molecular mechanisms of keratinizing ocular surface disease.
    McNamara NA
    Optom Vis Sci; 2010 Apr; 87(4):233-8. PubMed ID: 20010137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye.
    Chen YT; Li S; Nikulina K; Porco T; Gallup M; McNamara N
    Mol Vis; 2009; 15():563-76. PubMed ID: 19365590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pax6 downregulation mediates abnormal lineage commitment of the ocular surface epithelium in aqueous-deficient dry eye disease.
    Chen YT; Chen FY; Vijmasi T; Stephens DN; Gallup M; McNamara NA
    PLoS One; 2013; 8(10):e77286. PubMed ID: 24143217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell-derived thrombospondin-1 is critical for the generation of the ocular surface Th17 response to desiccating stress.
    Gandhi NB; Su Z; Zhang X; Volpe EA; Pelegrino FS; Rahman SA; Li DQ; Pflugfelder SC; de Paiva CS
    J Leukoc Biol; 2013 Dec; 94(6):1293-301. PubMed ID: 23983225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of human conjunctival epithelium proteome in ocular surface diseases using impression cytology and 2D-DIGE.
    Soria J; Acera A; Durán JA; Boto-de-Los-Bueis A; Del-Hierro-Zarzuelo A; González N; Reigada R; Suárez T
    Exp Eye Res; 2018 Feb; 167():31-43. PubMed ID: 28336260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular surface response of two preservative-free cylcosporine A emulsion eye drops in a mouse model of dry eye.
    Daull P; Nagano T; Gros E; Feraille L; Barabino S; Garrigue JS
    Curr Eye Res; 2021 Aug; 46(8):1096-1104. PubMed ID: 33588656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.
    Stern ME; Beuerman RW; Fox RI; Gao J; Mircheff AK; Pflugfelder SC
    Cornea; 1998 Nov; 17(6):584-9. PubMed ID: 9820935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis of ocular surface cells in experimentally induced dry eye.
    Yeh S; Song XJ; Farley W; Li DQ; Stern ME; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):124-9. PubMed ID: 12506064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.
    Wei Y; Epstein SP; Fukuoka S; Birmingham NP; Li XM; Asbell PA
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4780-8. PubMed ID: 21519031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfacial phenomena and the ocular surface.
    Yañez-Soto B; Mannis MJ; Schwab IR; Li JY; Leonard BC; Abbott NL; Murphy CJ
    Ocul Surf; 2014 Jul; 12(3):178-201. PubMed ID: 24999101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
    Zhu L; Zhang C; Chuck RS
    Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model.
    Simmons KT; Xiao Y; Pflugfelder SC; de Paiva CS
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2443-51. PubMed ID: 27136463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular surface keratinization as a predictor of response to topical retinoic acid therapy.
    Herbort CP; Weissman SS; Ostler HB; Cevallos A; Char DH
    Arch Ophthalmol; 1989 Sep; 107(9):1275-6. PubMed ID: 2476978
    [No Abstract]   [Full Text] [Related]  

  • 14. Reconsidering the central role of mucins in dry eye and ocular surface diseases.
    Baudouin C; Rolando M; Benitez Del Castillo JM; Messmer EM; Figueiredo FC; Irkec M; Van Setten G; Labetoulle M
    Prog Retin Eye Res; 2019 Jul; 71():68-87. PubMed ID: 30471351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impression cytology on conjunctiva and cornea in dry eye patients establishes a correlation between squamous metaplasia and dry eye clinical severity.
    Murube J; Rivas L
    Eur J Ophthalmol; 2003 Mar; 13(2):115-27. PubMed ID: 12696629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal tolerance disruption favors disease progression in an extraorbital lacrimal gland excision model of murine dry eye.
    Guzmán M; Keitelman I; Sabbione F; Trevani AS; Giordano MN; Galletti JG
    Exp Eye Res; 2016 Oct; 151():19-22. PubMed ID: 27443502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress.
    Yoon KC; Ahn KY; Choi W; Li Z; Choi JS; Lee SH; Park SH
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7267-73. PubMed ID: 21849424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.
    Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N
    Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Aberrant α(1,2)-Fucosylation at Ocular Surface Ameliorates Dry Eye Disease.
    Yoon CH; Ryu JS; Ko JH; Oh JY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.